Trilio-Medical

Company Overview

Snapshot

Founded in November 2022 by Yuval Raz, Trilio-Medical operates with 1–10 employees. The company has raised $2.1M across one funding round from one investor. In November 2022, Trilio-Medical secured seed funding from MEDX Xelerator.

Business overview

Trilio-Medical is a medical device company focused on developing a novel transcatheter implant and delivery system for tricuspid valve repair. The company’s innovative implant design aims to increase valve coaptation, providing a significant reduction in tricuspid regurgitation severity. Trilio-Medical operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics, serving the healthcare provider market in Israel and the United States.

Company Intelligence Q&A

When was Trilio-Medical founded?

Trilio-Medical was founded in November 2022.

Who is the founder of Trilio-Medical?

Yuval Raz is the Founder & CEO of Trilio-Medical.

What is Trilio-Medical's primary focus?

Trilio-Medical develops a novel transcatheter implant and delivery system for tricuspid valve repair, designed to increase valve coaptation and reduce tricuspid regurgitation severity.

In which sector does Trilio-Medical primarily operate?

Trilio-Medical operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices.